The nation of Zimbabwe has declined a significant American health deal worth 367 million US dollars (£272m) spanning five years over the United States' insistence on sensitive biological samples.
This move was revealed following a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "skewed".
An official representative later explained that the United States was requesting genetic material for scientific study and profit but was not willing to guarantee the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further dialogue to find a deal acceptable to all parties so the country's critical HIV programme can continue.
Wider Background
This rejection comes after a comparable situation in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were filed about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and accountability.
According to reports, Sixteen African countries have so far signed similar agreements, constituting over $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Put simply, our country would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our people if a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems already established through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This system is designed to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to further discussions with our American counterparts on how future collaboration might be structured in a manner that honours the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that talks need to persist given that much of the nation's Aids initiatives depended on international support.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group added.
The halted deal emphasises the complex debate between accepting vital international aid and safeguarding local interests in an ever more interconnected world.